Características clínicas y epidemiológicas de las neoplasias mieloproliferativas Philadelphia negativas en el sistema público de salud de Chile

• Autores: Ximena Valladares, Rafael Benavente, Christine Rojas, Camila Peña, Rodrigo Valenzuela, Virginia Monardes, Hernán López, Marcelo Abarca, Pilar León, Rocío Osorio, Erika Pérez, Pablo Soto, Gabriel La Rocca, Daniela Cardemil, Vivianne Torres, Marvila Intriago, María Elena Cabrera, María Soledad Undurraga
• Localización: Revista Médica de Chile, ISSN-e 0034-9887, Vol. 149, Nº. 11, 2021, págs. 1532-1538
• Idioma: español
• Títulos paralelos:
  • Clinical and epidemiological characteristics of the Philadelphia negative myeloproliferative neoplasms in Chile
• Enlaces
  • Texto completo
• Resumen

  • Background: Philadelphia-negative myeloproliferative neoplasms (Ph-MPN) are chronic hematological disorders characterized by the overproduction of one or more mature myeloid blood cell lineages. Classical Ph-MPN are polycythemia vera (PV), essential thrombocytopenia (ET) and primary myelofibrosis (PMF). Aim: To assess the epidemiological, clinical and diagnostic characteristics of Ph-MPN in Chile. Material and Methods: Retrospective review of medical records of all patients referred as MPN from 2012 to 2017. Patients with (9;21) translocation were excluded. Results: Data of 462 cases with a median age of 69 years from 10 public hospitals was reviewed. ET was the most frequently Ph-MNP found. The incidence of Ph-MPN was 1.5 x 100.000 cases. The JAK2 V617F mutation study was performed in 96% of patients and only 30% had a bone marrow biopsy. Thrombotic events were observed in 29% of patients. Bleeding events were observed in 7%. Five-year overall survival was 87%. Conclusions: ET is the most frequent Ph-MPN. The mean incidence was lower than reported in the literature, in part because of a sub diagnosis.